Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Is an Onslaught of Pain on the Horizon?

Vanessa Caceres  |  Issue: February 2011  |  February 12, 2011

The study’s results were so disparate that the U.S. Surgeon General at the time of the release of the study was prompted to explain the differences in care, although a true answer could not be given, Dr. Green said.

Both women and minority groups tend to experience chronic pain more often than other patient groups. Minorities report more pain, less access to pain management … and are at risk for undertreatment.

—Carmen R. Green, MD

A number of government- and organizational-based studies also found differences in pain treatment. The Institute of Medicine’s reports, “Unequal Treatment” and “To Err Is Human,” both find disparities in pain care, Dr. Green said.2,3 “Sadly, many patients fail to receive state-of-the-art pain relief,” she said, quoting a line from “Crossing the Quality Chasm,” another Institute of Medicine report.4 At the same time, healthcare expenses related to pain continue to be higher than those for cancer and diabetes combined, Dr. Green said.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Both women and minority groups tend to experience chronic pain more often than other patient groups, Dr. Green explained. “Minorities report more pain, less access to pain management … and are at risk for undertreatment,” she said. She shared some quotes from patients who were seeking pain treatment but never felt they received what they needed, such as the following from a female patient:

“I see my primary care physician every three months, and each time I was there he’d ask me why I am walking with a cane. I’d tell him it’s because of the pain in my back, that the arthritis pain kept getting worse, and Tylenol and physical therapy didn’t help me. I’d talk to other patients with arthritis who were taking opioids, but all I could get was Tylenol, and I knew there had to be something better.”

Sometimes the barriers to pain treatment are based on one’s neighborhood. Dr. Green cited data based on a zip-code study of certain neighborhoods in Michigan that found that those living in a mostly white neighborhood had a 90% chance of obtaining opioids at their local pharmacy compared with a 50% chance for those living in a mostly minority community.

Dr. Green said that future research should address whether or not disparities in pain treatment should actually be considered medical errors. “People go to the emergency room every day with high pain scores, and yet we send them out not really believing them. Is that a medical error?” she asked. She believes that the healthcare field in general and those who treat pain should focus more on access, assessment, treatment, and pain care.

Disparities Based on Location

Dr. Williams focused on pain treatment disparities for patients in rural settings.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsPain SyndromesSoft Tissue Pain Tagged with:2010 ACR/ARHP Annual Scientific MeetingFibromyalgiaPainpatient carerheumatologist

Related Articles

    Revising Fibromyalgia: One Year Later

    July 12, 2011

    The 2010 ACR fibromyalgia criteria capture the broader clinical picture and help ensure more appropriate diagnosis and management by primary care

    Is Fibromyalgia Overdiagnosed?

    October 10, 2016

    Are too many patients diagnosed with fibromyalgia? The co-authors of one new study believe that close to 75% of patients who have received a clinical fibromyalgia diagnosis do not meet the 2010 Preliminary American College of Rheumatology (ACR) Criteria for Fibromyalgia.1 They say these patients are false-positive and may be taking treatments they don’t need….

    Diagnosing & Caring for Patients with Fibromyalgia

    May 19, 2022

    Doebl et al. compared the effect of symptoms and the healthcare use of people with fibromyalgia with those who fulfilled the criteria for fibromyalgia but had not been diagnosed and those with chronic pain. They found patients diagnosed with fibromyalgia reported the poorest healthcare experiences and were more likely than other study participants to be unemployed due to health issues. Their findings reveal an urgent need exists for a model of care for patients with fibromyalgia.

    Treat-to-Target Strategy Evaluated for Fibromyalgia Care

    September 19, 2017

    Treat-to-target is a widely used approach for rheumatoid arthritis, in which rheumatologists prescribe treatments to reach established benchmarks of disease activity.1 Is it time for a similar approach for fibro­myalgia treatment, even though its pathogenesis, disease-activity measures and treatment algorithms are less well understood? Three fibromyalgia researchers present their case in a new paper, “Treat-to-Target…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences